Regulation of smooth muscle cell migration and integrin expression by the Gax transcription factor

Journal of Clinical Investigation

Volumn 104, Issue 10, 1999, Pages 1469-1480

  Witzenbichler, Bernhard ^a,b   Kureishi, Yasuko ^a   Luo, Zhengyu ^a   Le Roux, Aude ^c   Branellec, Didier ^c   Walsh, Kenneth ^a,d  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c SANOFI   (France)

^d Department of Emergency Medicine St Elizabeth's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE; HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; HOMEOBOX; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

EID: 0032701219     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7251     Document Type: Article

References (78)

1. Niehrs, C., Keller, R., Cho, K.W.Y., and De Robertis, E.M. 1993. The homeobox gene goosecoid controls cell migration in Xenopus embryos. Cell. 72:491-503.
2. Salser, S.J., and Kenyon, C. 1992. Activation of a C. elegans Antennapedia homologue in migrating cells controls their direction of migration. Nature. 155:255-258.
3. Gorski, D.H., Patel, C.V., and Walsh, K. 1993. Homeobox transcription factor regulation in the cardiovascular system. Trends Cardiovasc. Med. 3:184-190.
4. Olson, E.N., and Rosenthal, N. 1994. Homeobox genes and muscle patterning. Cell. 79:9-12.
5. Scott, M.P., Tamkun, J.W., and Hartzell, G.W. 1989. The structure and function of the homeodomain. Biochim. Biophys. Acta. 989:25-48.
6. Gorski, D.H., and Walsh, K. 1995. Mitogen-responsive nuclear factors that mediate growth control signals in vascular myocytes. Cardiovasc. Res. 30:585-592.
7. 1 transition in vascular smooth muscle cells. Mol. Cell. Biol. 13:3722-3733.
8. Yamashita, J., et al. 1997. Opposite regulation of gax homeobox expression by angiotensin II and C-type natriuretic peptide. Hypertension. 29:381-387.
9. Weir, L., Chen, D., Pastore, C., Isnet, J.M., and Walsh, K. 1995. Expression of gax, a growth arrest homeobox gene, is rapidly down-regulated in the rat carotid artery during the proliferative response to balloon injury. J. Biol. Chem. 270:5457-5461.
10. Skopicki, H.A., et al. 1997. Embryonic expression of the gax homeodomain protein in cardiac, smooth, and skeletal muscle. Circ. Res. 80:452-462.
11. Edmondson, D.G., Lyons, G.E., Martin, J.F., and Olson, E.N. 1994. Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development. 120:1251-1263.
12. Suzuki, E., Guo, K., Kolman, M., Yu, Y.-T., and Walsh, K. 1995. Serum induction of MEF2/RSRF expression in vascular myocytes is mediated at the level of transcription. Mol. Cell. Biol. 15:3415-3423.
13. Andres, V., Fisher, S., Wearsch, P., and Walsh, K. 1995. Regulation of gax homeobox gene transcription by a combination of positive factors including myocyte-specific enhancer factor 2. Mol. Cell. Biol. 15:4272-4281.
14. CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev. 11:1674-1689.
15. Schwartz, S.M., Campbell, G.R., and Campbell, J.H. 1986. Replication of smooth muscle cells in vascular disease. Circ. Res. 58:427-444.
16. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:801-809.
17. Casscells, W. 1992. Endothelial and smooth muscle cell migration: critical factors in restenosis. Circulation. 86:723-729.
18. Grotendorst, C.R., Chang, T., Seppa, H.E.J., Kleinman, H.K., and Martin, G.R. 1982. Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells. J. Cell Physiol. 113:261-266.
19. Bilato, C., et al. 1995. Intracellular signaling pathways required for rat vascular smooth muscle cell migration. J Clin. Invest. 96:1905-1915.
20. 1 integrin and disassembly of actin filaments. Circ. Res. 80:627-637.
21. Jackson, C.L., and Reidy, M.A. 1993. Basic fibroblast growth factor: its role in the control on smooth muscle cell migration. Am. J. Pathol. 143:1024-1031.
22. Boudreau, N., Turley, E., and Rabinovitch, M. 1991. Fibronectin, hyaluronan, and a hyaluronan binding protein contribute to increased ductus arteriosus smooth muscle cell migration. Dev. Biol. 143:235-247.
23. DiMilla, P.A., Stone, J.A., Quinn, J.A., Albelda, S.M., and Lauffenburger, D.A. 1993. Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at intermediate attachment strength. J. Cell Biol. 122:729-737.
24. Molossi, S., et al. 1995. Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment-1 peptide reduces accelerated coronary arteriopathy. J. Clin. Invest. 95:2601-2610.
25. Savani, R.C., et al. 1995. Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. J. Clin. Invest. 95:1158-1168.
26. Hynes, R.O. 1992. Integrins: versatility, modulation, and signalling in cell adhesion. Cell. 69:11-24.
27. Clyman, R.I., McDonald, K.A., and Kramer, R.H. 1990. Integrin receptors on aortic smooth muscle cells mediate adhesion to fibronectin, laminin, and collagen. Circ. Res. 67:175-186.
28. 1-like integrin receptor on rat aortic smooth muscle cells mediates adhesion to laminin and collagen types 1 and IV. Arteriosclerosis. 10:402-409.
29. Bottger, B.A., Hedin, U., Johansson, S., and Thyberg, J. 1989. Integrin-type fibronectin receptors of rat arterial smooth muscle cells: isolation, partial characterization and role in cytoskeletal organization and control of differentiated properties. Differentiation. 41:158-167.
30. Lee, R.T., Berditchevski, F., Cheng, G.C., and Hemler, M.E. 1995. Integrin-mediated collagen matrix reorganization by cultured human vascular smooth muscle cells. Circ. Res. 76:209-214.
31. 1 integrin is requited for chemotaxis across type I collagen coated membranes. Am. J. Pathol. 145:1070-1081.
32. Mader, S.L. 1992. Influence of animal age on the β-adrenergic system in cultured rat aortic and mesenteric artery smooth muscle cells. J. Gerontol. Biol. Sci. 47:B32-B36.
33. Pickering, J.G., et al. 1992. Smooth muscle cell outgrowth from human atherosclerotic plaque: implications for the assessment of lesion biology. J. Am. Coll. Cardiol. 20:1430-1439.
34. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell. 82:675-684.
35. Harvey, D., and Levine, A. 1991. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev. 5:2375-2385.
36. Koyama, H., Raines, E.W., Bornfeldt, K.E., Roberts, J.M., and Ross, R. 1996. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of cdk2 inhibitors. Cell. 87:1069-1078.
37. Clayman, G.L., et al. 1996. Gene therapy for head and neck cancer. Comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/CIP1 (p21).Arch. Otolaryngol. Head Neck Surg. 122:489-493.
38. Wang, J., Guo, K., Wills, K.N., and Walsh, K. 1997. Rb functions to inhibit apoptosis during myocyte differentiation. Cancer Res. 57:351-354.
39. Stratford-Perricaudes, L.D., Makeh, I., Perricaudet, M., and Briand, P. 1993. Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 90:626-630.
40. Buttke, T.M., McCubrey, J.A., and Owen, T.C. 1993. Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines. J. Immunol. Methods. 157:233-240.
41. Falk, W., Goodwin, R.H.J., and Leonard, E.J. 1980. A 48 well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J. Immunol. Meth. 33:239-247.
42. Pauly, R.R., et al. 1995. Role of calcium/calmodulin-dependent protein kinase II in the regulation of vascular smooth muscle cell migration. Circulation. 91:1107-1115.
43. Kundra, V., et al. 1994. Regulation of chemotaxis by the platelet-derived growth factor receptor-β. Nature. 367:474-476.
44. 2+. J. Cell Biol. 117:1109-1117.
45. Koyama, N., Hart, C.E., and Clowes, A.W. 1994. Different functions of the Platelet-derived growth factor-α and -β receptors for the migration and proliferation of cultured baboon smooth muscle cells. Circ. Res. 75:682-691.
46. Gruber, B., Marchese, M., and Kew, R. 1995. Angiogenic factors stimulate mast-cell migration. Blood. 86:2488-2493.
47. Clesham, G.J., Browne, H., Efstathiou, S., and Weissberg, P.L. 1996. Enhancer stimulation unmasks latent gene transfer after adenovirus-mediated gene delivery into human vascular smooth muscle cells. Circ. Res. 79:1188-1195.
48. Lee, S.W., Trapnell, B.C., Rade, J.J., Virmani, R., and Dichek, D.A. 1993. In vivo vector-mediated gene transfer into balloon-injured rat carotid arteries. Circ. Res. 73:797-807.
49. Perlman, H., et al. 1998. Bax-mediated cell death by the Gax homeoprotein requires mitogen-activation but is independent of cell cycle activity. EMBO J. 17:3576-3586.
50. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K., and Elledge, S.J. 1993. Thep21 Cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:805-816.
51. Grana, X., and Reddy, E.P. 1995. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene. 11:211-219.
52. Peter, M., and Herskowitz, I. 1994. Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell. 79:181-184.
53. El-Deiry, W.S., et al. 1993. WAF-1, a potential mediator of p53 tumor suppression. Cell. 75:817-825.
54. Seki, J., et al. 1996. Regulation of β1-integrin function in cultured human vascular smooth muscle cells. Circ. Res. 78:596-605.
55. 3 integrin. Exp. Cell Res. 214:459-464.
56. 3 integrins have different roles in the adhesion and migration of vascular smooth muscle cells on extracellular matrix. Exp. Cell Res. 200:272-284.
57. 3 binding to vitronectin. Nature. 383:441-443.
58. Maillard, L., et al. 1997. Percutaneous delivery of the gax gene inhibits vessel stenosis in a rabbit model of balloon angioplasty. Cardiovasc. Res. 35:536-546.
59. Perlman, H., et al. 1999. Adenoviral-mediated delivery of the Gax transcription factor to rat carotid arteries inhibits smooth muscle proliferation and induces apoptosis. Gene Ther. 6:758-763.
60. Stouffer, G., et al. 1998. Beta3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells. Circulation. 97:907-915.
61. Srivatsa,S., et al. 1997. Selective alpha v beta 3 integrin blockade potently limits neoinrimal hyperplasia and lumen stenosis following deep coronary arterial stent injury: evidence for the functional importance of integrin alpha v beta 3 and osteopontin expression during neointimal formation. Cardiovasc. Res. 36:408-428.
62. Schneider, C., King, R.M., and Philipson, L. 1988. Genes specifically expressed at growth arrest of mammalian cells. Cell. 54:787-793.
63. Fornace, A.J., Jackman, J., Hollander, M.C., Hoffman-Liebermann, B., and Liebermann, D.A. 1992. Genotoxic-stress-response genes and growth arrest genes: gadd, MyD, and other genes induced by treatments eliciting growth arrest. Ann. NY Acad. Sci. 643:139-153.
64. Bornfeldt, K.E., et al. 1994. Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J. Clin. Invest. 93:1266-1274.
65. Clowes, A.W., and Schwartz, S.M. 1985. Significance of quiescent smooch muscle migration in the injured rat carotid artery. Circ. Res. 56:139-145.
66. WAF1/CIP1 expression by vascular cell integrin αvβ3 during angiogenesis. J. Clin. Infest. 98:426-433.
67. Edelman, G.M., and Jones, F.S. 1993. Outside and downstream of the homeobox. J. Biol. Chem. 268:20683-20686.
68. 3 integrin with a small peptide antagonist GpenGRGDSPCA. J. Vasc. Surg. 19:125-134.
69. Matsuno, H., Stassen, J.M., Vermylen, J., and Deckmyn, H. 1994. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointimal formation. Circulation. 90:2203-2206.
70. Topol, E., et al. 1994. Randomized trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet. 343:881-886.
71. 3 for angiogenesis. Science. 264:569-571.
72. Clark, R.A.F., Tonnesen, M.G., Gailit, J., and Cheresh, D.A. 1996. Transient functional expression of alphavbeta 3 on vascular cells during wound repair. Am. J. Pathol. 148:1407-1421.
73. 3 antagonists promore further tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 79:1157-1164.
74. 3 integrin complex is reversed by activated calcium/calmodulin-dependent protein kinase II. J. Clin. Invest. 100:693-704.
75. Shattil, S.J., and Ginsberg, M.H. 1997. Perspectives series: cell adhesion in vascular biology. Integrin signaling in vascular biology. J. Clin. Invest. 100:1-5
76. Wei, G.L., et al. 1997. Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty. Circ. Res. 80:418-426.
77. Deitch, J., et al. 1998. Effects of beca3-integrin blockade (c7E3) on the response to angioplasty and intra-arterial stenting in atherosclerotic nonhuman primates. Arterioscler. Thromb. Vasc. Biol. 18:1730-1737.
78. 3 blockade is associated with smooth muscle cell apoptosis. Cell Adbes. Commun. 6:371-379.